VanEck Associates
ZLAB icon

VanEck Associates’s Zai Lab ZLAB Stock Holding History

VanEck Associates’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-340
Closed -$8K – 1435
2023
Q3 		$8K Buy
340
+202
+146% +$5.38K ﹤0.01% 1362
2023
Q2 		$4K Hold
138
– – ﹤0.01% 1388
2023
Q1 		$5K Sell
138
-4
-3% -$153 ﹤0.01% 1390
2022
Q4 		$4K Buy
142
+59
+71% +$1.86K ﹤0.01% 1406
2022
Q3 		$3K Buy
83
+38
+84% +$1.63K ﹤0.01% 1371
2022
Q2 		$2K Buy
45
+15
+50% +$529 ﹤0.01% 1361
2022
Q1 		$1K Hold
30
– – ﹤0.01% 1364
2021
Q4 		$2K Sell
30
-110,455
-100% -$9.37M ﹤0.01% 1364
2021
Q3 		$11.6M Sell
110,485
-66,350
-38% -$9.53M 0.03% 327
2021
Q2 		$31.3M Buy
176,835
+176,815
+884,075% +$28.4M 0.07% 209
2021
Q1 		$3K Buy
+20
New +$3.1K ﹤0.01% 1216

Other funds holding ZLAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates's ZLAB Position: Q4 2023 in Review

VanEck Associates sold out of Zai Lab (ZLAB) in Q4 2023, closing a stake of 340 shares — an estimated $8K sold.

VanEck Associates first reported a position in ZLAB in Q1 2021 and held it in 11 quarters. The position peaked at $31.3M in Q2 2021. 123 funds tracked by Wall St. Rank hold ZLAB as of Q4 2023.

  • VanEck Associates reported no remaining Zai Lab position as of Q4 2023 after selling out during the quarter.
  • VanEck Associates sold 340 Zai Lab shares in Q4 2023, an estimated $8K.
  • VanEck Associates first reported a position in Zai Lab in Q1 2021 and held it in 11 quarters.
  • VanEck Associates's Zai Lab position peaked at $31.3M in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Zai Lab as of Q4 2023.

Based on VanEck Associates's 13F filing for Q4 2023, filed 5 Feb 2024.